Treatment Patterns and Prognosis of Patients with Clear Cell Adenocarcinoma of the Cervix: A Population-Based Cohort Study

Treatment Patterns and Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Research Study Academic Background Cervical cancer ranks as the fourth most common gynecological malignancy globally and the third leading cause of cancer-related mortality in women. Among its subtypes, clear cell adenocarcinoma of the cervix (CCAC) is an extremely rare ...

Transcriptome Concordance Between Borderline Tumors and Endometrioid Carcinoma: An Integrative Genomic Analysis

Transcriptomic Concordance Between Borderline Ovarian Tumors and Endometrioid Carcinoma: A Research Study Background Introduction Borderline ovarian tumors (BOTs) are ovarian neoplasms that lie between benign and malignant tumors, typically occurring in young women. Although BOTs are clinically non-invasive, they can occasionally progress to malign...

Exploring Cervical Adenocarcinoma: Epidemiological Insights, Diagnostic and Therapeutic Challenges, and Pathogenetic Mechanisms

Exploring Cervical Adenocarcinoma: Epidemiology, Diagnostic and Therapeutic Challenges, and Pathogenetic Mechanisms Academic Background Cervical cancer poses a significant threat to women’s health globally, particularly in developing countries. The main histological types of cervical cancer include squamous cell carcinoma (SCC) and cervical adenoca...

Improving Image Quality and Decreasing SAR with High Dielectric Constant Pads in 3T Fetal MRI

Application of High Dielectric Constant Pads in 3T Fetal MRI Background Introduction With the advancement of medical imaging technology, fetal MRI (Magnetic Resonance Imaging) is increasingly being used in prenatal diagnosis. Compared to ultrasound, MRI provides higher soft tissue resolution and contrast, offering significant advantages in imaging ...

Metabolism of Primary High-Grade Serous Ovarian Carcinoma (HGSOC) Cells under Limited Glutamine or Glucose Availability

Metabolism of High-Grade Serous Ovarian Carcinoma (HGSOC) Cells Academic Background High-Grade Serous Ovarian Carcinoma (HGSOC) is the most common and aggressive subtype of epithelial ovarian cancer. Most patients are diagnosed at stage III or IV, with a 5-year survival rate ranging from 20% to 40%. Treatment for HGSOC typically involves surgical r...